Item 1.01 Entry into a Material Definitive Agreement.
On August 12, 2014 the registrant ("Viropro") entered into a convertible note
issued to Spring Hill Bioventures Sdn Bhd ("Spring Hill") in the principal
amount of $200,000 that matures in 12 months and bears interest at 12% per year.
The convertible note converts at a price of $0.01 per share and is issued in
connection with a warrant exercisable for ten years at an exercise price equal
to $0.06 per share, to purchase that number of shares of Viropro common stock
equal to 35% of the principal amount divided by $0.01 or 7,000,000 shares. The
note is subordinated to up to $1,000,000 of debt to banks or lending
institutions and has piggyback rights other than a registration under Form S-4
or Form S-8.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement of a Registrant.
The response to item 1.01 is incorporated by reference in response to Item 2.03.
The note may be accelerated if there is an event of a default, which is defined
as (a) a failure to make payment of principal and interest when due under the
note; (b) upon the filing by or against Viropro of any voluntary or involuntary
petition in bankruptcy or any petition for relief under the federal bankruptcy
code or any other state or federal law for the relief of debtors; provided,
however, with respect to an involuntary petition in bankruptcy, such petition
has not been dismissed within ninety (90) days after the filing of such
petition; (c) upon the execution by Viropro of an assignment for the benefit of
creditors or the appointment of a receiver, custodian, trustee or similar party
to take possession of Viropro's assets or property; (d) any breach of a material
representation or warranty under the note that cannot be cured in ten (10)
business days from the date the Company receives notice of such breach; (e) a
material default in performance or compliance with respect to any other debt
instrument in excess of $100,000 individually or in the aggregate (excluding the
note) that results in acceleration of the maturity date of such debt obligation
or that causes such indebtedness not to be paid when due; or (f) a material
adverse change in the financial condition of Viropro.
The foregoing description of the note does not purport to be complete and is
qualified in its entirety by reference to the note which is filed as Exhibit
10.1 to this Current Report on Form 8-K.
Viropro issued a press release on August 25, 2014 to disclose this event, a copy
of which is attached to this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
10.1 Convertible Note dated August 12, 2014
issued by Viropro
to Spring HillBioventures Sdn Bhd
99.1 Press Release dated August 25, 2014